Basit öğe kaydını göster

The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels

dc.contributor.authorErdenen, Fusun
dc.contributor.authorUzun, Hafize
dc.contributor.authorBesler, Mine
dc.contributor.authorSezgin, Can
dc.contributor.authorKonukoglu, Dildar
dc.contributor.authorMuderrisoglu, Cuneyt
dc.date.accessioned2021-03-04T14:26:12Z
dc.date.available2021-03-04T14:26:12Z
dc.date.issued2008
dc.identifier.citationUzun H., Konukoglu D., Besler M., Erdenen F., Sezgin C., Muderrisoglu C., "The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels", CLINICAL AND INVESTIGATIVE MEDICINE, cilt.31, sa.1, 2008
dc.identifier.issn0147-958X
dc.identifier.othervv_1032021
dc.identifier.otherav_818bebc5-0ca7-4b59-8956-f3655b9d2709
dc.identifier.urihttp://hdl.handle.net/20.500.12627/88295
dc.description.abstractPurpose: Asymmetric dimethylarginine (ADMA), nitric oxide (NOx), and C-reactive protein (CRP) are important risk factors for endothelial dysfunction and mortality in the end stage renal diseases population. The aim of the study was to investigate the relationship between renal replacement therapy and endothelial dysfunction.
dc.language.isoeng
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleThe effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels
dc.typeMakale
dc.relation.journalCLINICAL AND INVESTIGATIVE MEDICINE
dc.contributor.departmentIstanbul Training & Research Hospital , ,
dc.identifier.volume31
dc.identifier.issue1
dc.contributor.firstauthorID18755


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster